US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy

Clin Infect Dis. 2024 Mar 20;78(3):514-517. doi: 10.1093/cid/ciad659.

Abstract

The provision of tuberculosis-preventive therapy (TPT) to vulnerable populations is critical for global control. Shorter-course TPT regimens are highly effective and improve completion rates. Despite incorporation of 1 month of rifapentine and isoniazid into global guidelines, current US TPT guidelines do not include this as a recommended regimen, but should.

Keywords: 1 month rifapentine and isoniazid; 1HP; tuberculosis infection; tuberculosis preventive therapy.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Antibiotic Prophylaxis
  • Antitubercular Agents / therapeutic use
  • Drug Therapy, Combination
  • Humans
  • Isoniazid / therapeutic use
  • Latent Tuberculosis* / drug therapy
  • Tuberculosis* / drug therapy
  • Tuberculosis* / prevention & control

Substances

  • Isoniazid
  • Antitubercular Agents